Received Aug 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (NOVAVAX)) | NOVAVAX | UNK | — | OT / LA |
Mild inflammation on his knee after having the Novavax vaccine; This non-serious initial spontaneous report was reported by a consumer or other non-health professional via contact center (MI No. NOV25-00632) and concerns an elderly Male who experienced "MILD INFLAMMATION ON HIS KNEE AFTER HAVING THE NOVAVAX VACCINE" after receiving Novavax COVID-19 Vaccine, Adjuvanted (2024 - 2025 Formula) on 02-Oct-2024. At the time of the report, the outcome of the Arthritis was Recovered/Resolved. A few discrepancies were identified in the source document. Patient's age group was reported as "Adult" but was captured as "Elderly" according to the reported date of birth. The Novavax vaccination information reported for the 'Body Site Location' of the product administration was provided as "Left". Left arm was conservatively selected and will be confirmed with the query sent to the consumer.; Sender's Comments: This Male of an unspecified age experienced Arthritis after vaccination with Novavax COVID-19 Vaccine, Adjuvanted (2024 - 2025 Formula). The event Arthritis was reported as non-serious. Based on the spontaneous nature of the report, the causal relationship between Novavax COVID-19 Vaccine, Adjuvanted (2024 - 2025 Formula) and Arthritis is considered Possible.
Drug allergy; Lactose intolerant; Penicillin allergy
Medical History/Concurrent Conditions: Amoebic dysentery; Arthritis; Escherichia infection; Fracture bone; Knee reconstruction; Malaria; MRI; Old disruption of anterior cruciate ligament; Old disruption of lateral collateral ligament; Old disruption of medial collateral ligament; Rotator cuff injury; Shingles; Stem cell therapy; Traumatic brain injury
Standard vitamins